Results 41 to 50 of about 22,963 (277)

A critical balance between Pax8 and the Hippo mediator TAZ determines sodium-iodide symporter NIS expression and function.

open access: yesThyroid, 2021
BACKGROUND The Hippo pathway has a fundamental role in tissue homeostasis, but little is known about how this signaling cascade is controlled in the thyroid.
C. Fernández-Méndez, P. Santisteban
semanticscholar   +1 more source

Iodine status in Turkish populations and exposure to iodide uptake inhibitors. [PDF]

open access: yesPLoS ONE, 2014
Perchlorate, nitrate, and thiocyanate are competitive inhibitors of the sodium iodide symporter of the thyroid membrane. These inhibitors can decrease iodine uptake by the symporter into the thyroid gland and may disrupt thyroid function.
Aysel Ozpinar   +14 more
doaj   +1 more source

Distribution and dynamics of Tc-99m-pertechnetate uptake in the thyroid and other organs assessed by single-photon emission computed tomography in living mice [PDF]

open access: yes, 2010
Background: Tc-99m pertechnetate is a well-known anion, used for clinical imaging of thyroid function. This gamma emitter is transported by the sodium iodide symporter but is not incorporated into thyroglobulin. Scintigraphy using Tc-99m pertechnetate or
Darcourt, Jacques   +6 more
core   +1 more source

Downregulation of miR-146b-3p Inhibits Proliferation and Migration and Modulates the Expression and Location of Sodium/Iodide Symporter in Dedifferentiated Thyroid Cancer by Potentially Targeting MUC20

open access: yesFrontiers in Oncology, 2021
The dedifferentiation of differentiated thyroid cancer (DTC) is a challenging problem for radioactive iodine (131I) treatment, also known as radioiodine refractory differentiated thyroid cancer (RAIR-DTC). The purpose of this study was to further explore
Shasha Hou   +7 more
semanticscholar   +1 more source

Modulation of Sodium Iodide Symporter in Thyroid Cancer [PDF]

open access: yesHormones and Cancer, 2014
Radioactive iodine (RAI) is a key therapeutic modality for thyroid cancer. Loss of RAI uptake in thyroid cancer inversely correlates with patient's survival. In this review, we focus on the challenges encountered in delivering sufficient doses of I-131 to eradicate metastatic lesions without increasing the risk of unwanted side effects.
Daniel Scarberry   +3 more
openaire   +3 more sources

Genetic Factors That Might Lead to Different Responses in Individuals Exposed to Perchlorate [PDF]

open access: yes, 2005
Perchlorate has been detected in groundwater in many parts of the United States, and recent detection in vegetable and dairy food products indicates that contamination by perchlorate is more widespread than previously thought.
Fowler, Bruce A.   +4 more
core   +2 more sources

Functional characterization of human thyroid tissue with immunohistochemistry [PDF]

open access: yes, 2007
Immunohistochemistry provides insights in the expression of functional proteins and of their localization in normal thyroid tissue and in thyroid diseases.
Bernard, Caillou   +6 more
core   +1 more source

Advances in the design and development of oncolytic measles viruses. [PDF]

open access: yes, 2015
A successful oncolytic virus is one that selectively propagates and destroys cancerous tissue without causing excessive damage to the normal surrounding tissue. Oncolytic measles virus (MV) is one such virus that exhibits this characteristic and thus has
Hutzen, Brian   +2 more
core   +1 more source

Characterization of the Sodium Iodide Symporter Binding Sites [PDF]

open access: yesBiophysical Journal, 2015
Sodium iodide symporter (NIS) is a membrane protein responsible for accumulation of iodide (I-) in the thyroid and other organs. This is accomplished through active transports in which the sodium (Na+) gradient provides the driving force. In our approach we attempt to bring together the most recent finding on the NIS homologous systems and shine light ...
Sergei Y. Noskov   +3 more
openaire   +2 more sources

Regression of experimental NIS-expressing breast cancer brain metastases in response to radioiodide/gemcitabine dual therapy. [PDF]

open access: yes, 2016
Treating breast cancer brain metastases (BCBMs) is challenging. Na+/I- symporter (NIS) expression in BCBMs would permit their selective targeting with radioiodide (131I-).
Ahmad   +46 more
core   +1 more source

Home - About - Disclaimer - Privacy